KEVIN M. LALANDE Transaction History

Date Transaction Value Shares Traded Form
Sep 08 2021
BUY
Open market or private purchase
$112,100 $11.21 p/Share
10,000
Sep 07 2021
BUY
Open market or private purchase
$111,100 $11.11 p/Share
10,000
Sep 03 2021
BUY
Open market or private purchase
$91,935 $11.35 p/Share
8,100
Sep 02 2021
BUY
Open market or private purchase
$70,749 $11.23 p/Share
6,300
Sep 01 2021
BUY
Open market or private purchase
$49,882 $10.87 p/Share
4,589
Aug 31 2021
BUY
Open market or private purchase
$64,200 $10.7 p/Share
6,000
Aug 30 2021
BUY
Open market or private purchase
$90,735 $10.52 p/Share
8,625
Aug 27 2021
BUY
Open market or private purchase
$52,300 $10.5 p/Share
4,981
Aug 26 2021
BUY
Open market or private purchase
$62,434 $10.07 p/Share
6,200
Aug 25 2021
BUY
Open market or private purchase
$147,063 $9.87 p/Share
14,900
Aug 24 2021
BUY
Open market or private purchase
$101,824 $9.45 p/Share
10,775
Aug 23 2021
BUY
Open market or private purchase
$362,124 $9.58 p/Share
37,800
Aug 20 2021
BUY
Open market or private purchase
$311,478 $8.73 p/Share
35,679
Aug 19 2021
BUY
Open market or private purchase
$169,000 $8.45 p/Share
20,000
Aug 18 2021
BUY
Open market or private purchase
$252,035 $8.73 p/Share
28,870
Aug 17 2021
BUY
Open market or private purchase
$135,520 $8.47 p/Share
16,000
Aug 16 2021
BUY
Open market or private purchase
$246,760 $7.96 p/Share
31,000
Aug 13 2021
BUY
Open market or private purchase
$243,660 $7.86 p/Share
31,000
Aug 12 2021
BUY
Open market or private purchase
$234,050 $7.55 p/Share
31,000

Also insider at

MTEM
Molecular Templates, Inc. Healthcare
KML

Kevin M. Lalande

Director
Austin, TX

Track Institutional and Insider Activities on LUMO

Follow LUMOS PHARMA, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LUMO shares.

Notify only if

Insider Trading

Get notified when an Lumos Pharma, Inc. insider buys or sells LUMO shares.

Notify only if

News

Receive news related to LUMOS PHARMA, INC.

Track Activities on LUMO